False susceptibility to cefotetan reported by MicroScan for DHA-type AmpC β-lactamase-producing Klebsiella pneumoniae

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study evaluated the accuracy of cefotetan susceptibility determination using the MicroScan WalkAway system for AmpC-producing Klebsiella pneumoniae. In total, 57 K. pneumoniae isolates that showed a D-shape flattening in a double-disk synergy test were studied. Cefotetan MICs were determined by the agar dilution method. The blaDHA gene was detected in all 57 isolates, one of which co-harboured blaCMY-1. According to the MicroScan system, 28 isolates were susceptible, 18 were intermediately-resistant, and 11 were resistant to cefotetan. Compared with the agar dilution method, very major, minor and major error rates were 28.1% (16/57), 47.4% (27/57) and 1.8% (1/57), respectively. © 2007 European Society of Clinical Microbiology and Infectious Diseases.

Cite

CITATION STYLE

APA

Lee, S. Y., Park, Y. J., Oh, E. J., Yoo, J. K., Park, J. J., Park, K. G., & Han, K. (2007). False susceptibility to cefotetan reported by MicroScan for DHA-type AmpC β-lactamase-producing Klebsiella pneumoniae. Clinical Microbiology and Infection, 13(5), 539–541. https://doi.org/10.1111/j.1469-0691.2007.01695.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free